NCT00412997View on ClinicalTrials.gov

LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

May 31, 2008

Conditions
TumorsCutaneous T-Cell Lymphoma
Interventions
DRUG

LBH589

Trial Locations (1)

Unknown

Novartis Investigative Site, Tokyo

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00412997 - LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma | Biotech Hunter | Biotech Hunter